CURRENT APPROACHES TO CONTROL OF ISONIAZID-RESISTANT TUBERCULOSIS
Isoniazid (H; INH) is an important first-line drug for the treatment of active tuberculosis (TB) and latent TB infection because of its potent early bactericidal activity against Мycobacterium tuberculosis. Currently, TB resistant to INH, alone or in combination with other drugs, is the most common...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
National Center of Infectious and Parasitic Diseases
2022-10-01
|
Series: | Problems of Infectious and Parasitic Diseases |
Subjects: | |
Online Access: | https://pipd.ncipd.org/index.php/pipd/article/view/83 |